跳至主要内容
临床试验/NCT07361588
NCT07361588尚未招募不适用

Feasibility Study for VCool™ Intranasal Cooling System in Healthy Volunteers

NeuroIntact Inc.1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2026年1月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10
试验地点
1
主要终点
lower core body temperature

研究概览

简要总结

The objective of this study is to evaluate the performance and safety of the VCool Intranasal Cooling System in healthy adult volunteers. The study is designed to gather preliminary data regarding air flow rates and time required to reduce core body temperature to 35.5℃ and maintain the temperature between 35℃ and 36℃ for one hour after cooling.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female ages 18 to
  • An Institutional Review Board (IRB) approved informed consent is signed and dated prior to any study-related activities.
  • Baseline core body temperature between 36.8℃ and 37.5℃.
  • Have the ability to understand the requirements of the study and are willing to comply with all study procedures.
  • In the opinion of the Investigator, are able to participate in the study.

排除标准

  • History of cardiovascular, respiratory, or metabolic disorder
  • Any contraindication to undergoing Magnetic Resonance Imaging (MRI)
  • Severe peripheral vascular disease
  • History of Raynaud's disease
  • Currently experiencing a respiratory infection
  • Chronic rhinosinusitis
  • History of sickle cell disease
  • History of cold agglutinin disease
  • History of cryoglobulinemia
  • Known deviated septum or nasal deformity
  • History of nosebleeds or a nosebleed within past 24 hours
  • Use of antipyretics or other medications affecting body temperature within the past 24 hours.

研究组 & 干预措施

Healthy adult volunteers

Experimental

The study is designed to gather preliminary data regarding air flow rates and time required to reduce core body temperature to 35.5℃ and maintain the temperature between 35℃ and 36℃ for one hour after cooling.

干预措施: Targeted Temperature Management Intranasal Cooling System (Device)

结局指标

主要结局

lower core body temperature

时间窗: 1 hour

To confirm the VCool System can lower core body temperature to 35.5℃.

maintain a core body temperature

时间窗: 1 hour

To confirm the VCool System can maintain a core body temperature between 35℃ and 36℃ for one hour after cooling.

differential between core body and brain temperature

时间窗: 2 hours

To evaluate the differential between core body and brain temperature while using VCool.

次要结局

  • Bedside Shivering Assessment Scale (BSAS).(2 hours)

研究者

发起方
NeuroIntact Inc.
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Bryan Wand

Director of Engineering

NeuroIntact Inc.

研究点 (1)

Loading locations...

相似试验